Brief: Quantum Genomics: Data Demonstrate Efficacy Of QGC006 As An Antihypertensive Agent
May 10 (Reuters) - Quantum Genomics SA ALQGC.PA :
* REPORTED DATA DEMONSTRATE EFFICACY OF QGC006 AS AN ANTIHYPERTENSIVE AGENT
* QGC006 INDUCES A SIGNIFICANT DECREASE IN BLOOD PRESSURE IN DOCA-SALT RATS
ASSOCIATED WITH INCREASED DIURESIS
* IT REINFORCE RESULTS ALREADY OBTAINED WITH FIRIBASTAT, VALIDATE
THERAPEUTIC
VALUE OF BRAIN AMINOPEPTIDASE A INHIBITORS FOR TREATMENT OF HYPERTENSION
Source text for Eikon: ID:nACT58390
Further company coverage: ALQGC.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Quantum Genomics SA
See all newsBrief: Quantum Genomics Announces Resumption Of Discussions With HealthTech, Terminates Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO
Brief: Quantum Genomics In Talks For New Strategic Project
Brief: Quantum Genomics Announces Lack Of Significant Efficacy For Firibastat In Their Phase Iii Study